Functional genomics identifies therapeutic targets for MYC-driven cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional genomics identifies therapeutic targets for MYC-driven cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 24, Pages 9545-9550
Publisher
Proceedings of the National Academy of Sciences
Online
2012-05-24
DOI
10.1073/pnas.1121119109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYC-Driven Tumorigenesis Is Inhibited by WRN Syndrome Gene Deficiency
- (2012) R. Moser et al. MOLECULAR CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
- (2011) D. Blazek et al. GENES & DEVELOPMENT
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
- (2011) J. D. Kessler et al. SCIENCE
- c-Myc Regulates Transcriptional Pause Release
- (2010) Peter B. Rahl et al. CELL
- CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1
- (2010) B. Bartkowiak et al. GENES & DEVELOPMENT
- Casein kinase I epsilon somatic mutations found in breast cancer cause overgrowth in Drosophila
- (2010) Tomas Dolezal et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
- (2010) So Young Kim et al. PLoS One
- Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase
- (2010) D. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Inhibition of Casein Kinase 1 Minimally Alters Circadian Clock Period
- (2009) K. M. Walton et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Stabilizers of the Max Homodimer Identified in Virtual Ligand Screening Inhibit Myc Function
- (2009) H. Jiang et al. MOLECULAR PHARMACOLOGY
- Genome-wide identification of post-translational modulators of transcription factor activity in human B cells
- (2009) Kai Wang et al. NATURE BIOTECHNOLOGY
- Cdk2 suppresses cellular senescence induced by the c-myc oncogene
- (2009) Stefano Campaner et al. NATURE CELL BIOLOGY
- c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
- (2009) Kristin Robinson et al. PLoS One
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
- (2008) Maria Barna et al. NATURE
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2008) Julie R. Park et al. PEDIATRIC CLINICS OF NORTH AMERICA
- New Regulators of Wnt/ -Catenin Signaling Revealed by Integrative Molecular Screening
- (2008) M. B. Major et al. Science Signaling
- Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest
- (2008) Wan Seok Yang et al. GENOME BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started